Details For Selected Brain Tumor Treatment

Sponsored By

Please Click On The Above Banner For More Details

Last updated refers to the date when our listing for each treatment was last updated.
ID is our internal ID - starting with VT.
Min Karnofsky is a general guide to how well you have to function to use this treatment
For trials that also have a NCT number, you can click that number to pop up the listing from the clinicaltrials.gov website.

Back to New Treatments List



		Treatment Name:		Phase I/II Trial of Imatinib Mesylate; (Gleevec; ST1571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma

		Keywords:		Gleevec (Imatinib Mesylate)

		Phase:		Phase 1/2

		Treatment ID#s:		VT1624 NCT00049127

		Age Group:		Adults Only

		Min Karnofsky Score:		60: Requires occasional assistance but is able to care for most of own needs

		Conditions:		Newly Diagnosed: N Recurrent: Y Prior Surgery is Allowed Prior Radiation is Allowed Prior Chemotherapy is Sometimes Allowed Histologically confirmed oligodendroglioma or mixed oligoastrocytoma Grade 2-4 Recurrent disease Failed prior surgery, radiotherapy, nitrosourea-based therapy, or temozolomide chemotherapy regimen Progressive disease by MRI or CT scan No more than 2 prior chemotherapy regimens No prior or concurrent significant intratumoral hemorrhage

		Last Updated:		06/26/2006

		Tumor Types:		Mixed Glioma Oligodendroglioma High Grade Oligodendroglioma Low Grade


		Comments:		No prior interstitial chemotherapy, including carmustine wafers, unless separate lesion seen on MRI outside of prior treatment field

		Treatment Type:		Chemotherapy.

		Contact:		Mayo Clinic-Cancer Clinical Studies Unit Kurt Jaeckle, MD 4500 San Pablo Road Jacksonville, FL 32224 Phone:904-953-6806 Email not available Mayo Clinic Cancer Center - FL Toni Kay Mangskau-FL Clinical Trials Referral Coordinator 4500 San Pablo Road Jacksonville, FL 32224 Phone:(507)538-7623 Click here to send an email Website: www.mayoclinic.org/cancer-treatment/ CCOP - Iowa Oncology Research Association Roscoe F. Morton, MD, FACP Des Moines, IA 50309-1016 Phone:515-244-7586 Email not available Trinity Medical Center - East Stewart C. Garneau, MD Moline, IL 61265 Phone:309-779-4800 Email not available CCOP - Illinois Oncology Research Association John Kugler, MD Peoria, IL 61615-7828 Phone:309-243-3605 Email not available CCOP - Carle Cancer Center Kendrith Rowland, MD Urbana, IL 61801 Phone:217-383-4083 Click here to send an email CCOP - Wichita Shaker R. Dakhil, MD Wichita, KS 67214-3882 Phone:316-268-5784 Email not available Haematology-Oncology Associates of Ohio and Michigan, P.C., Paul L. Schaefer, MD Lambertville, MI 48144 Phone:419-843-6147 Email not available Mayo Clinic Cancer Center - MN Toni Kay Mangskau-MN Clinical Trials Referral Coordinator 200 First Street SW Rochester, MN 55905 Phone:(507)538-7623 Click here to send an email Website: www.mayoclinic.org/cancer-treatment/ CCOP - Metro-Minnesota Patrick J. Flynn, MD Saint Louis Park, MN 55416 Phone:612-863-8585 Email not available CCOP - Montana Cancer Consortium Patrick W. Cobb, MD Billings, MT 59101 Phone:406-259-2245 Email not available Bismarck Cancer Center Edward J. Wos, DO Bismarck, ND 58501 Phone:701-323-5741 Email not available Bryan LGH Medical Center West Alan R. Berg, MD Lincoln, NE 68502 Phone:402-420-7000 Email not available Geisinger Medical Center Albert M. Bernath, MD Danville, PA 17822-2001 Phone:570-214-9290 Email not available CCOP - Upstate Carolina James Dewitt Bearden, MD Spartanburg, SC 29303 Phone:864-560-7050 Email not available CCOP - Sioux Community Cancer Consortium Loren K. Tschetter, MD Sioux Falls, SD 57104 Phone:605-328-8044 Click here to send an email

Translate this pageMicrosoftÂ® Translator

Copyright (c) 1993 - 2010 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740

Website Design By